Abstract
Despite important improvements in the multimodal treatment of upper gastrointestinal tumors in recent years, surgery is still the standard of care and the best way to cure and palliate patients with esophageal cancer. There has been significant improvement in both clinical oncologic staging and functional preoperative evaluation of patients in the last few decades. Despite improvements, esophagectomy is still associated with high operative risk. Diligent perioperative evaluation and risk stratification lead to better outcomes.